Clinical Trial Update: National Survey on Gastroesophageal Reflux Disease (GERD) Patients

View source ↗

Summary

A completed AstraZeneca-sponsored clinical trial survey evaluating patients with gastroesophageal reflux disease (GERD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Status: COMPLETED